MAHBOOB ALAM to Anticoagulants
This is a "connection" page, showing publications MAHBOOB ALAM has written about Anticoagulants.
Connection Strength
0.504
-
Meta-Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease. Clin Cardiol. 2024 Oct; 47(10):e70026.
Score: 0.157
-
Association of Body Mass Index With Outcomes in Patients Undergoing Percutaneous Left Atrial Appendage Closure With the Watchman Device. Curr Probl Cardiol. 2022 12; 47(12):101009.
Score: 0.127
-
Safety and Efficacy of Apixaban, Rivaroxaban, and Warfarin in End-Stage Renal Disease With Atrial Fibrillation: A Systematic Review and Meta-Analysis. Cardiovasc Revasc Med. 2021 09; 30:26-32.
Score: 0.119
-
Bivalirudin Versus Heparin in Patients Undergoing Percutaneous Coronary Intervention in Acute Coronary Syndromes. Crit Pathw Cardiol. 2025 Mar 01; 24(1):e0372.
Score: 0.040
-
Contemporary trends in utilization and outcomes of percutaneous left atrial appendage occlusion in the United States from 2016 to 2019. Heart Rhythm. 2023 02; 20(2):313-314.
Score: 0.034
-
Risk Assessment of Stroke in Patients with Atrial Fibrillation: Current Shortcomings and Future Directions. Cardiovasc Drugs Ther. 2019 02; 33(1):105-117.
Score: 0.026